Reports for ALLERGAN INC
Company Name
ALLERGAN INC
Totals |
||
Shortage reports |
102 |
|
| Actual shortage: | 6 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 3 (3%) | |
| Resolved: | 93 (91%) | |
Discontinuation Reports |
21 |
|
| To be discontinued: | 4 (19%) | |
| Discontinued: | 16 (76%) | |
| Reversed: | 1 (5%) | |
Late reports |
19 (15%) |
|
Overdue reports |
7 (70%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| BYSTOLIC | 2.5MG | TABLET | Resolved | 2019-05-25 | 2019-06-07 | 84750 |
| BYSTOLIC | 5.0MG | TABLET | Resolved | 2018-12-05 | 2019-02-08 | 68675 |
| BYSTOLIC | 5.0MG | TABLET | Resolved | 2019-05-25 | 2019-06-07 | 84758 |
| BYSTOLIC | 5MG | TABLET | Actual shortage | 2022-03-17 | 2022-06-01 | 156945 |
| BYSTOLIC | 10.0MG | TABLET | Resolved | 2019-01-29 | 2019-02-22 | 73787 |
| BYSTOLIC | 10.0MG | TABLET | Resolved | 2019-05-25 | 2019-06-06 | 84746 |
| BYSTOLIC | 20.0MG | TABLET | Resolved | 2019-05-25 | 2019-06-07 | 84755 |
| BYSTOLIC | 20MG | TABLET | Actual shortage | 2022-01-20 | 2022-01-21 | 153204 |
| CONSTELLA | 145MCG | CAPSULE | Resolved | 2019-05-25 | 2019-06-11 | 84767 |
| CONSTELLA | 290MCG | CAPSULE | Resolved | 2018-11-20 | 2019-01-09 | 67153 |
| CONSTELLA | 290MCG | CAPSULE | Resolved | 2019-02-19 | 2019-02-27 | 76263 |
| CONSTELLA | 290MCG | CAPSULE | Resolved | 2019-05-25 | 2019-06-07 | 84770 |
| CONSTELLA | 290MCG | CAPSULE | Actual shortage | 2022-06-09 | 2022-06-10 | 162248 |
| CONSTELLA | 72MCG | CAPSULE | Resolved | 2019-05-25 | 2019-06-07 | 84773 |
| CONSTELLA | 72MCG | CAPSULE | Actual shortage | 2022-06-09 | 2022-06-10 | 162251 |
| FETZIMA | 20MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-05-25 | 2019-06-07 | 84776 |
| FETZIMA | 80MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-05-25 | 2019-06-07 | 84779 |
| FIBRISTAL | 5MG | TABLET | Resolved | 2020-09-24 | 2020-10-23 | 125019 |
| FML 0.1% | 0.1% | DROPS | Resolved | 2019-08-14 | 2019-09-21 | 91579 |
| FML 0.1% | 0.1% | DROPS | Resolved | 2019-10-24 | 2019-11-08 | 97085 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ALOCRIL | 2% | LIQUID | Discontinued | 2018-11-28 | 2019-04-02 | 67803 |
| ALPHAGAN | 0.2% | LIQUID | To be discontinued | 2021-12-09 | 2021-12-09 | 150885 |
| ANDRODERM | 5MG | PATCH | Discontinued | 2021-11-26 | 2021-11-26 | 150081 |
| ANDRODERM | 2.5MG | PATCH | Discontinued | 2022-03-14 | 2022-03-14 | 156691 |
| ASACOL | 400MG | TABLET (ENTERIC-COATED) | Discontinued | 2020-07-31 | 2020-07-31 | 121616 |
| ASACOL 800 | 800MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-01-28 | 2021-01-28 | 132579 |
| BETAGAN 0.5% OPHTHALMIC SOL | 5MG | LIQUID | Discontinued | 2020-03-10 | 2020-03-10 | 108380 |
| BETAGAN OPH SOLN 0.25% | 0.25% | LIQUID | Discontinued | 2017-08-04 | 2017-08-04 | 18275 |
| BLEPHAMIDE | 0.2% 10% | DROPS | To be discontinued | 2021-12-02 | 2021-12-02 | 150359 |
| BLEPHAMIDE S.O.P. | 0.2% 10% | OINTMENT | Discontinued | 2019-07-31 | 2019-07-31 | 90343 |
| FIBRISTAL | 5MG | TABLET | Discontinued | 2020-10-06 | 2020-10-06 | 125735 |
| LOESTRIN 1.5/30 | 30MCG 1.5MG | TABLET | Discontinued | 2021-06-25 | 2021-06-26 | 141494 |
| MACROBID | 100MG | CAPSULE | Discontinued | 2021-06-16 | 2021-08-19 | 141050 |
| OPTICROM | 2% | SOLUTION | Discontinued | 2021-03-10 | 2021-03-10 | 135410 |
| PRED MILD | 0.12% | DROPS | Discontinued | 2021-12-09 | 2022-04-01 | 150889 |
| RAPAFLO | 4MG | CAPSULE | Discontinued | 2021-11-17 | 2021-11-17 | 149528 |
| RAPAFLO | 8MG | CAPSULE | To be discontinued | 2021-11-17 | 2022-03-15 | 149531 |
| TAZORAC | 0.05% | GEL | Discontinued | 2021-11-26 | 2021-11-27 | 149997 |
| TAZORAC | 0.1% | CREAM | Discontinued | 2021-11-26 | 2022-03-14 | 150061 |
| VIBERZI | 75MG | TABLET | To be discontinued | 2022-03-23 | 2022-03-23 | 157156 |